Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.

Moussa O, Yordy JS, Abol-Enein H, Sinha D, Bissada NK, Halushka PV, Ghoneim MA, Watson DK.

Cancer Res. 2005 Dec 15;65(24):11581-7.

2.

Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents.

Moussa O, Riker JM, Klein J, Fraig M, Halushka PV, Watson DK.

Oncogene. 2008 Jan 3;27(1):55-62.

PMID:
17603559
3.
4.

Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.

Wang X, Colby JK, Rengel RC, Fischer SM, Clinton SK, Klein RD.

Mol Carcinog. 2009 Jan;48(1):1-13. doi: 10.1002/mc.20449.

PMID:
18444251
5.

[Correlation of clusterin expression to prognosis of bladder carcinoma].

Luo JH, Xie D, Chen W, Dai YP, Li XF, Tao Y, Zheng KL.

Ai Zheng. 2005 Jun;24(6):743-7. Chinese.

PMID:
15946493
6.

Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer.

Fauconnet S, Bernardini S, Lascombe I, Boiteux G, Clairotte A, Monnien F, Chabannes E, Bittard H.

Oncol Rep. 2009 Jun;21(6):1495-504.

PMID:
19424629
7.

Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis.

Moussa O, Ashton AW, Fraig M, Garrett-Mayer E, Ghoneim MA, Halushka PV, Watson DK.

Cancer Res. 2008 Jun 1;68(11):4097-104. doi: 10.1158/0008-5472.CAN-07-6560.

8.

Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.

Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R.

Oncol Rep. 2006 Aug;16(2):329-34.

PMID:
16820911
9.

Bladder cancer outcome and subtype classification by gene expression.

Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, Waldman FM.

Clin Cancer Res. 2005 Jun 1;11(11):4044-55.

10.

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.

Urology. 2007 Sep;70(3):482-6.

PMID:
17905101
11.

Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?

Hameed DA, Abdel Raheem AM, Mosad E, Hammouda HM, Kamel NA, Abdel Aziz MA.

Urology. 2008 Aug;72(2):374-8. doi: 10.1016/j.urology.2007.12.063.

PMID:
18342927
12.

Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction.

Meyers FJ, Gumerlock PH, Kawasaki ES, Wang AM, deVere White RW, Erlich HA.

Cancer. 1991 Apr 15;67(8):2087-95.

13.

[The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues].

Ren L, Hou SK, He LF, Ye HY, Guan KP.

Zhonghua Wai Ke Za Zhi. 2004 Sep 22;42(18):1104-7. Chinese.

PMID:
15498296
14.

Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.

Simonetti S, Russo R, Ciancia G, Altieri V, De Rosa G, Insabato L.

Int J Surg Pathol. 2009 Jun;17(3):198-205. doi: 10.1177/1066896909333415.

PMID:
19443884
15.

Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder.

Margulis V, Shariat SF, Ashfaq R, Thompson M, Sagalowsky AI, Hsieh JT, Lotan Y.

J Urol. 2007 Mar;177(3):1163-8.

PMID:
17296438
16.

Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.

Christoph F, Weikert S, Wolff I, Schostak M, Tabiti K, Müller M, Miller K, Schrader M.

Cancer Lett. 2007 Jan 8;245(1-2):121-6.

PMID:
16473461
17.

Association between clinical characteristics and expression abundance of RTKN gene in human bladder carcinoma tissues from Chinese patients.

Fan J, Ma LJ, Xia SJ, Yu L, Fu Q, Wu CQ, Huang XH, Jiang JM, Tang XD.

J Cancer Res Clin Oncol. 2005 Mar;131(3):157-62.

PMID:
15599595
18.

Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.

Gildea JJ, Golden WL, Harding MA, Theodorescu D.

Genes Chromosomes Cancer. 2000 Mar;27(3):252-63.

PMID:
10679914
19.

Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?

Soukup V, Babjuk M, Dusková J, Pesl M, Szakáczová M, Zámecník L, Dvorácek J.

Urol Int. 2008;80(4):413-8. doi: 10.1159/000132700.

PMID:
18587253
20.

Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder.

Das K, Zhao Y, Sugiono M, Lau W, Tan PH, Cheng C.

Urol Oncol. 2007 Jul-Aug;25(4):317-21.

PMID:
17628298

Supplemental Content

Support Center